Shenyang Xingqi Pharmaceutical Co.,Ltd
SZSE:300573.SZ
150.38 (CNY) • At close October 26, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets: | |||||||||||||
| Current Assets: | |||||||||||||
| Cash & Cash Equivalents
| 480.418 | 515.45 | 686.36 | 37.219 | 49.963 | 28.371 | 22.286 | 90.612 | 10.831 | 20.896 | 52.021 | 98.993 | 96.555 |
| Short Term Investments
| 0 | 0 | 0 | 0 | -16.01 | -15.868 | -4.307 | 0 | 0 | 0 | -0 | 0 | 0 |
| Cash and Short Term Investments
| 480.418 | 515.45 | 686.36 | 37.219 | 49.963 | 28.371 | 22.286 | 90.612 | 10.831 | 20.896 | 52.021 | 98.993 | 96.555 |
| Net Receivables
| 257.008 | 218.049 | 199.583 | 178.497 | 145.873 | 121.41 | 117.043 | 105.797 | 98.297 | 106.264 | 67.119 | 74.965 | 76.15 |
| Inventory
| 136.025 | 122.271 | 92.331 | 68.31 | 79.867 | 56.315 | 54.83 | 48.104 | 38.698 | 39.39 | 23.859 | 13.492 | 8.875 |
| Other Current Assets
| 31.737 | 9.398 | 6.148 | 10.19 | 6.073 | 3.67 | 0.331 | -0.55 | -5.857 | -18.209 | -4.053 | -2.471 | 1.258 |
| Total Current Assets
| 905.189 | 865.168 | 984.422 | 294.216 | 281.776 | 209.766 | 194.491 | 243.963 | 141.97 | 148.342 | 138.946 | 184.98 | 182.838 |
| Non-Current Assets: | |||||||||||||
| Property, Plant & Equipment, Net
| 870.031 | 695.924 | 548.598 | 527.895 | 474.253 | 425.029 | 430.825 | 443.199 | 478.149 | 493.268 | 393.07 | 183.858 | 54.79 |
| Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 188.221 | 123.259 | 73.849 | 45.434 | 25.083 | 23.492 | 24.075 | 24.034 | 26.093 | 26.807 | 27.602 | 28.072 | 28.6 |
| Goodwill and Intangible Assets
| 188.221 | 123.259 | 73.849 | 45.434 | 25.083 | 23.492 | 24.075 | 24.034 | 26.093 | 26.807 | 27.602 | 28.072 | 28.6 |
| Long Term Investments
| 13.001 | 11.508 | 22.015 | 17.013 | 18.206 | 18.063 | 6.502 | 3.157 | 0.5 | 0.5 | 0.5 | 0.5 | 0 |
| Tax Assets
| 38.575 | 23.772 | 30.446 | 33.873 | 13.28 | 5.73 | 5.515 | 5.547 | 2.946 | 1.12 | 0.903 | 2.161 | 1.156 |
| Other Non-Current Assets
| 8.829 | 63.313 | 27.515 | 47.271 | 39.771 | 26.389 | 15.069 | 1.513 | 1.283 | 0.866 | 6.188 | 18.45 | 0.5 |
| Total Non-Current Assets
| 1,118.656 | 917.775 | 702.423 | 671.485 | 570.592 | 498.703 | 481.986 | 477.45 | 508.971 | 522.56 | 428.263 | 233.042 | 85.046 |
| Total Assets
| 2,023.845 | 1,782.943 | 1,686.844 | 965.701 | 852.368 | 708.469 | 676.476 | 721.414 | 650.941 | 670.902 | 567.208 | 418.021 | 267.884 |
| Liabilities & Equity: | |||||||||||||
| Current Liabilities: | |||||||||||||
| Account Payables
| 17.565 | 19.455 | 13.312 | 6.665 | 26.519 | 10.571 | 6.909 | 10.194 | 6.132 | 8.662 | 28.198 | 1.199 | 1.551 |
| Short Term Debt
| 88.874 | 7.116 | 104.179 | 80 | 90 | 50 | 50 | 108 | 98 | 99 | 65.7 | 0 | 0 |
| Tax Payables
| 5.741 | 8.915 | 20.743 | 6.34 | 12.523 | 3.805 | 7.802 | 11.634 | 9.651 | 8.166 | 3.799 | 5.933 | 6.767 |
| Deferred Revenue
| 6.763 | 2.239 | 137.832 | 116.035 | 86.656 | 3.805 | 34.497 | 49.442 | 98.88 | 111.954 | 51.69 | 0 | 0 |
| Other Current Liabilities
| 146.916 | 123.635 | 11.506 | 9.793 | 17.893 | 59.724 | 0.709 | 0.554 | 0.159 | 0.145 | 0.078 | 54.648 | 14.402 |
| Total Current Liabilities
| 260.119 | 152.445 | 266.829 | 212.493 | 221.068 | 124.1 | 92.116 | 168.19 | 203.171 | 219.76 | 145.667 | 55.847 | 15.952 |
| Non-Current Liabilities: | |||||||||||||
| Long Term Debt
| 2.224 | 6.693 | 7.101 | 29.903 | 0 | 0 | 0 | 0 | 20 | 56 | 60 | 60 | 0 |
| Deferred Revenue Non-Current
| 71.581 | 71.496 | 68.421 | 59.149 | 56.396 | 29.791 | 30.978 | 32.278 | 37.979 | 27.329 | 24.74 | 11.47 | 4.93 |
| Deferred Tax Liabilities Non-Current
| -71.581 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -20 | -56 | -17.54 | -8.27 | 0 |
| Other Non-Current Liabilities
| 71.581 | 0 | 0 | -29.903 | 0 | 0 | 0 | 0 | 20 | 56 | 17.54 | 8.27 | 0 |
| Total Non-Current Liabilities
| 73.805 | 78.189 | 75.522 | 59.149 | 56.396 | 29.791 | 30.978 | 32.278 | 57.979 | 83.329 | 84.74 | 71.47 | 4.93 |
| Total Liabilities
| 333.924 | 230.634 | 342.351 | 271.642 | 277.465 | 153.891 | 123.093 | 200.468 | 261.15 | 303.09 | 230.407 | 127.317 | 20.882 |
| Equity: | |||||||||||||
| Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Common Stock
| 124.589 | 88.555 | 88.096 | 82.365 | 82.43 | 82.43 | 80 | 80 | 60 | 60 | 60 | 60 | 60 |
| Retained Earnings
| 614.384 | 567.119 | 434.949 | 285.93 | 213.555 | 204.124 | 212.433 | 187.218 | 138.449 | 118.872 | 91.09 | 49.642 | 10.32 |
| Accumulated Other Comprehensive Income/Loss
| 164.071 | 118.566 | 95.016 | 63.699 | 26.698 | 11.32 | 28.035 | 23.813 | 191.342 | 0 | 0 | 0 | 0 |
| Other Total Stockholders Equity
| 786.876 | 778.069 | 726.433 | 250.195 | 245.831 | 247.653 | 229.914 | 229.914 | -0 | 188.94 | 185.712 | 181.062 | 176.681 |
| Total Shareholders Equity
| 1,689.921 | 1,552.309 | 1,344.493 | 682.189 | 568.514 | 545.527 | 550.382 | 520.945 | 389.791 | 367.812 | 336.801 | 290.704 | 247.001 |
| Total Equity
| 1,689.921 | 1,552.309 | 1,344.493 | 694.059 | 574.903 | 554.577 | 553.383 | 520.945 | 389.791 | 367.812 | 336.801 | 290.704 | 247.001 |
| Total Liabilities & Shareholders Equity
| 2,023.845 | 1,782.943 | 1,686.844 | 965.701 | 852.368 | 708.469 | 676.476 | 721.414 | 650.941 | 670.902 | 567.208 | 418.021 | 267.884 |